One study reported a temporal relationship between the presence of HA-1-specific T cells and GHVD early post-HCT (70), but HA-1-specific T cells have been identified in patients without GVHD following DLI therapy (51, 71–73). This evidence concerns the gene ARHGAP45 and graft versus host disease.